Progress in Novel Ultradeformable Vesicular Drug Carrier in the Topical and Transdermal Treatment of Psoriasis

References

• Unissa R , KumarPM , PashaM , BegumS , MaheswariB. Psoriasis: a comprehensive review. Asian J. Res. Pharm. Sci.9(1), 29 (2019).
   Google Scholar
• Chiu HY , WangTS , ChenPH , HsuSH , TsaiYC , TsaiTF. Psoriasis in Taiwan: from epidemiology to new treatments. Dermatologica Sin.36(3), 115–123 (2018).
   Web of Science ®Google Scholar
• Laws PM , YoungHS. Update of the management of chronic psoriasis: new approaches and emerging treatment options. Clin. Cosmet. Investig. Dermatol.3, 25–37 (2010).
   PubMedGoogle Scholar
• Lo KK , HoLY. Psoriasis. In: Handbook of Dermatology and Venereology.Social Hygiene Service D of Health, Hong Kong, (1997).
   Google Scholar
• Fernandes AR , Martins-GomesC , SantiniA , SilvaAM , SoutoEB. Psoriasis vulgaris-pathophysiology of the disease and its classical treatment versus new drug delivery systems. Des. Nanostructures Versatile Ther. Appl. Chapter 9, 279–406 (2018).
   Google Scholar
• Krishna V , SinghviG , KumarS , GuptaG , KumarD , DuaK. Biomedicine & pharmacotherapy emerging landscape in psoriasis management: from topical application to targeting biomolecules. Biomed. Pharmacother.106, 707–713 (2018).
   PubMedGoogle Scholar
• Pradhan M , AlexanderA , SinghMRet al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed. Pharmacother.107(2), 447–463 (2018).
   PubMedGoogle Scholar
• Slominski AT , ZmijewskiMA , ZbytekB , TobinDJ , TheoharidesTC , RivierJ. Key role of CRF in the skin stress response system. Endocr. Rev.34(6), 827–884 (2013).
   PubMed Web of Science ®Google Scholar
• Witman PM . Topical therapies for localized psoriasis. Mayo Clinic Proceedings.76(9), 943–949 (2001).
   PubMed Web of Science ®Google Scholar
• Godin B , TouitouE. Encyclopedia of Nanotechnology. Springer, The Netherlands, 1–12 (2016).
   Google Scholar
• Culty M , LiuY , MankuG , ChanWY , PapadopoulosV. Expression of steroidogenesis-related genes in murine male germ cells. Steroids103, 105–114 (2015).
   PubMed Web of Science ®Google Scholar
• Slominski RM , TuckeyRC , MannaPRet al. Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders. Genes Immun.21(3), 150–168 (2020).
   PubMed Web of Science ®Google Scholar
• Katare OP , RazaK , SinghB , DograS. Novel drug delivery systems in topical treatment of psoriasis:Rigors and vigors. Indian J. Dermatol. Venereol. Leprol.76(6), 612–621 (2010).
   PubMed Web of Science ®Google Scholar
• Sashi K , SatinderK , BharatP. A complete review on: liposomes. Int. Res. J. Pharm.3(7), 10–16 (2012).
   Google Scholar
• Jadhav SM , MoreyP , KarpeMM , KadamV. Novel vesicular system:an overview. J. Appl. Pharm. Sci.2(1), 198–202 (2012).
   Google Scholar
• Bhatia A , KumarR. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J. Pharm. Sci.7(2), 252–259 (2004).
   Web of Science ®Google Scholar
• Sudhakar CK , JainS , CharyuliuRN. A comparison study of liposomes, transfersomes and ethosomes bearing lamivudine. Int. J. Pharm. Sci. Res.7(10), 4214–4221 (2016).
   Web of Science ®Google Scholar
• Abhinav K , LalPJ , AmitJ , VishwabhanS. Review on niosomes as novel drug delivery system. Int. Res. J. Pharm.2(5), 61–65 (2011).
   Google Scholar
• Talegaonkar S , AzeemA , AhmadFJ , KharRK , PathanSK , KhanZI. Microemulsions: a novel approach to enhanced drug delivery. Recent Pat. Drug Deliv. Formul.2, 238–257 (2008).
   PubMedGoogle Scholar
• Cevc G , VierlU. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J. Control. Rel.3(141), 277–299 (2010).
   Google Scholar
• Jain S , UmamaheswariRB , BhadraD , TripathiP , JainP , JainNK. Ultradeformable liposomes: a recent tool for effective transdermal drug delivery. Indian J. Pharm. Sci.65(3), 223–231 (2003).
   Google Scholar
• Pawar A , JadhavKR , ChaudhariLH. Transfersome: a novel technique which improves transdermal permeability. Asian J. Pharm.2016(4), 425–436 (2016).
   Google Scholar
• Bibi N , AhmedN , KhanGM. Nanostructures in Transdermal Drug Delivery Systems.Elsevier Inc.
   Google Scholar
• Prajapati ST , PatelCG , PatelCN , PatelN. Transfersomes: a vesicular carrier system for transdermal drug delivery. Asian J. Biochem. Pharm. Res.1, 507–524 (2011).
   Google Scholar
• Rane BR (P. S. G. V. P. Mandal's College of Pharmacy, India) , GujarathiNA (P. S. G. V. P. Mandal's College of Pharmacy India). Transfersomes and protransfersome: ultradeformable vesicular system. In: Novel Approaches for Drug Delivery. IGI Global Publisher, USA, 21 (2017).
   Google Scholar
• Zhdanov RI , PodobedOV , VlassovVV. Cationic lipid–DNA complexes – lipoplexes – for gene transfer and therapy. Biochemistry58(1), 53–64 (2002).
   Google Scholar
• Amnuaikit T , LimsuwanT , KhongkowP , BoonmeP. Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes. Asian J. Pharm. Sci.13(5), 472–484 (2018).
   PubMed Web of Science ®Google Scholar
• Saraf S , PaliwalS , SarafS. Sphingosomes a novel appoach to vesicular drug delivery. Int. J. Cur. Sci. Res.2, 63–68 (2011).
   Google Scholar
• Suryawanshi JAS . Phytosome: an emerging trend in herbal drug treatment. J. Med. Genet. Genomics.3, 109–114 (2011).
   Google Scholar
• Jain S , JainV , MahajanSC. Lipid based vesicular drug delivery systems. Adv. Pharmaceutics.2014, 1–12 (2014).
   Google Scholar
• Ashara KC , SoniwalaMM , PaunJ , MoriN , ShahK. Vesicular drug delivery system: a novel approach. Mintage J. Pharm. Med. Sci.Vol 3(Suppl. 3), 1–14 (2014).
   Google Scholar
• Rafiqi UN , GulI , SaifiMet al. Cloning, identification, and in silico analysis of terpene synthases involved in the competing pathway of artemisinin biosynthesis pathway in Artemisia annua L. Pharmacogn. Mag.15(62), S38–S46 (2019).
   Web of Science ®Google Scholar
• Pradhan M , SinghD , SinghMR. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J. Control. Rel.170(3), 380–395 (2013).
   PubMed Web of Science ®Google Scholar
• Trotta M , PeiraraE , CarlottiME , GallarateM. Deformable liposome for dermal administration of methotrexate. Int. J. Pharm.270, 119–125 (2004).
   PubMed Web of Science ®Google Scholar
• Cevc G , BlumeG , SchatzleinA. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J. Control. Rel.45, 211–226 (1997).
   Web of Science ®Google Scholar
• Cevc G , BlumeG. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim. Biophys. Acta1663(1–2), 61–73 (2004).
   PubMed Web of Science ®Google Scholar
• Sharma A , DubeyA , GuptaP , YadavR , SaraogiR. Transferosome: novel drug delivery system. Int. J. Biol. Pharm. Res.3, 722–728 (2012).
   Google Scholar
• Chauhan N , KumarK , PantNC. An updated review on transfersomes: a novel vesicular system for transdermal drug delivery. Univers. J. Pharm. Res.2(4), 49–52 (2017).
   Google Scholar
• Nimisha DA , FatimaZ , NeemaCD. ntipsoriatic and anti-inflammatory studies of Berberis aristata extract loaded nanovesicular gels. A. Pharmacognosy magazine13(Suppl. 3), S587–Lpage (2017).
   PubMedGoogle Scholar
• Modi CD , BharadiaPD. Transfersomes: new dominants for transdermal drug delivery. Am. J. Pharm.2, 72–91 (2012).
   Google Scholar
• Vijaya Laxmi M , ZafaruddinMD , KuchanaV. Design and characterization of transferosomal gel of repaglinide. Int. Res. J. Pharm.6, 38–42 (2015).
   Google Scholar
• Kulkarni R , YadavJD , VaidyaKA , GandhiPP. Transferosomes: an emerging tool for transdermal drug delivery. Int. J. Pharm. Sci. Res.2, 735–741 (2011).
   Google Scholar
• Cevc G , BlumeG , SchatzleinA. Transfersomes mediates transepidermal delivery immproves the regiospecificity and biological activity of corticosteroids in vivo. J. Control. Rel.45, 211–226 (1997).
   Web of Science ®Google Scholar
• Gamal M , MaghrabyE , WilliamsAC , BarryBW. Skin delivery of oestrdiiol from deformable and traditional liposomes. J. Pharm. Pharmacol.51(10), 1123–1134 (1995).
   Google Scholar
• Scha Tzlein A , CevcG. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol.138, 583–592 (1998).
   PubMed Web of Science ®Google Scholar
• Sachan R , ParasharT , SoniyaSVet al. Drug carrier transfersomes: a novel tool for transdermal drug delivery system. Int. J. Res. Dev. Pharm. Life Sci.2(2), 309–316 (2013). http://www.ijrdpl.com
   Google Scholar
• Walve JR , BakliwalSR , RaneBR , PawarSP. Transfersomes: a Surrogated carrier for transdermal drug delivery system. Int. J. Appl. Biol. Pharm. Technol.2(1), 204–213 (2011).
   Google Scholar
• Bhasin B , LondheVY. An overview of transfersomal drug delivery. Int. J. Pharm. Sci. Res.9(6), 2175–2184 (2018).
   Google Scholar
• Zhou X , HaoY , YuanLet al. Nano-formulations for transdermal drug delivery: a review. Chinese Chem. Lett.29(12), 1713–1724 (2018).
   Web of Science ®Google Scholar
• Pawar AY , JadhavKR , ChaudhariLH. Transfersome: a novel technique which improves transdermal permeability. Asian J. Pharm.10(4), 425–436 (2016).
   Google Scholar
• Cevc G . Isothermal lipid phase transitions. Chemistry and Physics of Lipids57(2-3),293–307 (1991).
   PubMed Web of Science ®Google Scholar
• Cevc G . Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst.13(3–4), 257–388 (1996).
   PubMed Web of Science ®Google Scholar
• Dhopavkar S , KaduP. Transfersomes - a boon for transdermal delivery. Int. J. Pharm. Pharm. Res.4(09), 2908–2919 (2017).
   Google Scholar
• Rai S , PandeyV , RaiG. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev. Exp.8(1), 1325708 (2017).
   PubMed Web of Science ®Google Scholar
• Malakar J , SenSO , NayakAK , SenKK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm. J.20(4), 355–363 (2012).
   PubMed Web of Science ®Google Scholar
• Sheo DM , ShwetaA , RamCD , GhanshyamM , GirishK , SunilK. Transfersomes – a novel vesicular carrier for enhanced transdermal delivery of stavudine: development, characterization and performance evaluation. J. Sci. Speculations Res.1(1), 30–36 (2010).
   Google Scholar
• Gupta A , AggarwalG , SinglaS , AroraR. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization, and performance evaluation. Sci. Pharm.80(4), 1061 (2012).
   PubMedGoogle Scholar
• Solanki D , KushwahL , MotiwaleM , ChouhanV. Transferosomes – a review. World J. Pharm. Pharmaceut. Sci.49(5), 435–49 (2016).
   Google Scholar
• Kombath RV , MinumulaSK , SockalingamAet al. Critical issues related to transfersomes – novel vesicular system. Acta Sci. Pol. Technol. Aliment.1(11), 67–82 (2012).
   Google Scholar
• Shashank J , NiketkumarP , MansiKSet al. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J. Pharm. Sci.116, 1–23 (2016).
   Google Scholar
• Woo HJ , CarraroC , ChandlerD. Assembly of extended interfaces and micelles: charge frustrated models of amphiphilic mixtures. Faraday Discussions104, 183–191 (1996).
   Web of Science ®Google Scholar
• Irfan M , VermaSR. Alpana Preparation and Characterization of Ibuprofen loaded transfersomes as a novel carrier for transdermal drug delivery. Asian J. Pharm. Clin. Res.5(3), 162–165 (2012).
   Google Scholar
• Narvekar MNG , RedkarMMR , BhosaleMNS. Self-assembled ultradeformable phospholipid vesicles with edge activators for delivery of transcutaneous bioactives. Indo. Am. J. Pharm. Res.9(12), 543–552 (2019).
   Google Scholar
• Modi CD , BharadiaPD. Transfersomes: new dominants for transdermal drug delivery. Am. J. Pharmatech. Res.2, 72–91 (2012).
   Google Scholar
• Pathomthat S , ThongnopnuaP , RatktnonvhaiU. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int. J. Pharm.427(2), 426–434 (2012).
   PubMedGoogle Scholar
• Fernandes AR , Martins-GomesC , SantiniA , SilvaAM , SoutoEB. Psoriasis vulgaris – pathophysiology of the disease and its classical treatment versus new drug delivery systems. In: Design of Nanostructures for Versatile Therapeutic Applications.William Andrew Publishing, 379–406 (2018).
   Google Scholar
• Roy SB , KothariJS , SheikhS , PatelJD , PancholiJS. Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis. United States patent US 9,789,123. 2017 (2017).
   Google Scholar
• Pawar JS , RogeAB , VadvalkarSM. Novel approach in transdermal drug delivery system: transferosome. Res. J. Pharm. Technol.6, 17–21 (2013).
   Google Scholar
• Bhatia A , SinghB , WadhwaS , RazaK , KatareOP. Novel phospholipid-based topical formulations of tamoxifen: evaluation for antipsoriatic activity using mouse-tail model. Pharm. Dev. Technol.19(2), 160–163 (2014).
   PubMed Web of Science ®Google Scholar
• Kroon H-A et al. Vesicular formulation.
   Google Scholar
• Naeff R et al. Liposome-based topical vitamin D formulation.
   Google Scholar
• Gidwani SK et al. Composition for delivery of dithranol.
   Google Scholar
• Cevc G . Formulation for topical non-invasive application in vivo.
   Google Scholar
• Kapoor B , GuptaR , GulatiM , SinghSK , KhursheedR , GuptaM. The why, where, who, how, and what of the vesicular delivery systems. Adv. Colloid Interface Sci.271, 101985 (2019).
   PubMed Web of Science ®Google Scholar
• Kumar R , KumarS , JhaSS , JhaAK. Vesicular system-carrier for drug delivery. 2(4), 192–202 (2011).
   Google Scholar
• Rother M , SeidelEJ , ClarksonPM , MazgareanuS , VierlU , RotherI. Efficacy of epicutaneous Diractin® (ketoprofen in Transfersome® gel) for the treatment of pain related to eccentric muscle contractions. Drug Des. Devel. Ther.19(4), 143–149 (2009).
   Google Scholar
• Fernández-García R , LalatsaA , StattsL , Bolás-FernándezF , BallesterosMP , SerranoDR. Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale. Int. J. Pharm.573(2019), 118817 (2020).
   PubMedGoogle Scholar
• Ahad A , AqilM , KohliK , SultanaY. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine8(2), 237–249 (2012).
   PubMed Web of Science ®Google Scholar
• Rai S , PandeyV , RaiG. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev. Exp.8(1), 1325708 (2017).
   PubMed Web of Science ®Google Scholar
• Khan MA , PanditJ , SultanaYet al. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment:in vitrocharacterization andin vivostudy. Drug Deliv.22(6), 795–802 (2014).
   PubMed Web of Science ®Google Scholar
• Ascenso A , SalgadoA , EuletérioCet al. In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles. Eur. J. Pharm. Biopharm.88(1), 48–55 (2014).
   PubMed Web of Science ®Google Scholar